Single-use, point-of-care and home-use diagnostic test designed for qualitative detection of immunoglobulin antibodies to COVID-19 virus.

• Uses finger prick whole blood or plasma samples.
• Provides rapid results: 15 minutes and no more than 20 minutes
• Intuitive visual interpretation
• Detects IgM (live, active antibodies indicating recent infection and beginning phase and contagious)
• Detects IgG (antibodies formed to protect against bacterial and viral infections and generally appears post IgM in mid to late phase and recovery)
• Failure rate: less than 1%
• FDA approved
• Accuracy of 94.10% (compared to RT-PCR of 88.03% accuracy)